Clinical trial
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer
NCT00109811
Study timeline
Study start (unknown)2005-03-01Date precision: month
Registry last updated2013-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Interventions
PSA:154-163(155L) peptide vaccineBIOLOGICAL
incomplete Freund's adjuvantBIOLOGICAL
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00109811 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.